EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 1-May-2025 11:08 ET (1-May-2025 15:08 GMT/UTC)

MD Anderson Research Highlights for December 18, 2024

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

Ochsner Health Network announces multi-million dollar, record-breaking healthcare savings

Ochsner Health System
Business Announcement

Ochsner Health Network, LLC (OHN), the region’s largest physician-led clinically integrated network, is pleased to report its 2023 – 2024 impact resulting from care delivered to over a half million patients living throughout the Gulf South.

MSK Research Highlights, December 18, 2024

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

New research from Memorial Sloan Kettering Cancer Center (MSK) uncovers clues about how cells control a key DNA repair protein; develops a new method for studying gene amplifications in cancer; sheds new light on tumor suppressor genes; shows MSK-IMPACT^® could be used for HLA genotype screening to predict response to cellular therapies; identifies a possible strategy to overcome immune evasion in ovarian cancer; and finds strong support for telemedicine visits among cancer patients.

Influencers: Their power is real when a person has cancer

University of Rochester Medical Center
Grant and Award Announcement

Investigators study how a person's social networks influence their decisions about cancer care.

Funder: NIH/National Cancer Institute

BU researcher awarded NIH grant to further the understanding of neuroblastoma

Boston University School of Medicine
Grant and Award Announcement

Hui Feng, MD, PhD, associate professor of pharmacology, physiology & biophysics and medicine at Boston University Chobanian & Avedisian School of Medicine, has received an RO1 grant from the National Institutes of Health’s National Institute of Neurological Disorders and Stroke. The five-year, $3.1M award will support the project, “Mechanisms of Immunosuppression in MYCN-driven Neuroblastoma.” Feng will team with Derin Keskin, PhD, from the Dana-Farber Cancer Institute on this study.

Breast cancer battle: Precision subtyping leads to personalized treatment

China Anti-Cancer Association
Peer-Reviewed Publication

In a triumph for precision medicine, a pioneering study has unlocked the potential to revolutionize breast cancer treatment.

Journal: Cancer Biology & Medicine

ISS National Lab-sponsored projects on cancer, neurodegenerative conditions, and more return from space station

International Space Station U.S. National Laboratory
Business Announcement

Research that could enable early cancer detection, advance treatments for neurodegenerative conditions, and improve respiratory therapies returned from the International Space Station (ISSInternational Space Station) on SpaceX’s 31st Commercial Resupply Services (CRS) mission for NASANational Aeronautics and Space Administration. SpaceX’s Dragon spacecraft splashed down off the coast of Florida with nearly 50 biotechnology, physical science, and student research payloads sponsored by the ISS National Laboratory®.

Finally some evidence to guide health status measurement

Mary Ann Liebert, Inc./Genetic Engineering News
Peer-Reviewed Publication

New Rochelle, NY, December 18, 2024–A scoping review of indices to measure a community’s health status is published in the peer-reviewed journal Population Health Management.

Journal: Population Health Management

Nature’s instructions: How fungi make a key medicinal molecule

University of Pennsylvania School of Engineering and Applied Science
Peer-Reviewed Publication

Researchers at Penn Engineering have decoded the genetic blueprint of Penicillium citrinum, a common citrus mold, to uncover how nature produces cyclopentachromone — a key building block for bioactive compounds with potential in cancer and inflammation treatments. The team identified a previously unknown enzyme, IscL, that creates a highly reactive sulfur-containing intermediate, offering new insights into fungal chemistry. This discovery could pave the way for novel pharmaceuticals by harnessing nature’s molecular tools.

Journal: Journal of the American Chemical Society
Funder: NIH/National Institutes of Health

Children’s Hospital Colorado research transforms the standard of care for childhood cancer

Children's Hospital Colorado
Peer-Reviewed Publication

After participating in a global clinical trial, leaders at the Children’s Hospital Colorado (Children’s Colorado) Center for Cancer and Blood Disorders and the University of Colorado Cancer Center are celebrating results so transformative, they change the standard of care for treating most kids with B-cell acute lymphoblastic leukemia (B-ALL), the most common form of childhood cancer. The new therapy is less toxic than traditional chemotherapy, resulting in significantly fewer side effects like severe infections, mouth sores and bone marrow suppression, leading to improved quality of life for patients.

Journal: New England Journal of Medicine
Funder: NIH/National Cancer Institute, St. Baldrick's Foundation, Amgen